Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP
26/06/2026 12:16
BRIEF-Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP June 26 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O:
DAYBU® (TROFINETIDE) RECOMMENDED FOR APPROVAL IN THE EUROPEAN UNION BY CHMP
ACADIA PHARMACEUTICALS - EUROPEAN COMMISSION DECISION ON DAYBU EXPECTED IN COMING MONTHS
ACADIA PHARMACEUTICALS - DAYBU MARKETING AUTHORIZATION WOULD COVER EU, ICELAND, LIECHTENSTEIN, NORWAY IF APPROVED
Source text: ID:nBw7Y5MF9a
Further company coverage: ACAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP